FHND004 inhibits malignant proliferation of multiple myeloma by targeting PDZ-binding kinase in MAPK pathway
Aging · 2024
DOI: 10.18632/aging.205634 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2024. Verfasst von Hongjie Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Multiple Myeloma, Mitogen-Activated Protein Kinase Kinases. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing, China.
- School of Medicine and Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
Zitieren
APA
Wu, H., Qian, J., Zhou, L., Hu, T., Zhang, Y., Wang, C., Yang, Y., & Gu, C. (2024). FHND004 inhibits malignant proliferation of multiple myeloma by targeting PDZ-binding kinase in MAPK pathway. Aging. https://doi.org/10.18632/aging.205634
Vancouver
Wu H, Qian J, Zhou L, Hu T, Zhang Y, Wang C, et al. FHND004 inhibits malignant proliferation of multiple myeloma by targeting PDZ-binding kinase in MAPK pathway. Aging. 2024. doi:10.18632/aging.205634
BibTeX
@article{Wu2024,
author = {Wu, Hongjie and Qian, Jinjun and Zhou, Lianxin and Hu, Tingting and Zhang, Yuanjiao and Wang, Chen and Yang, Ye and Gu, Chunyan},
title = {FHND004 inhibits malignant proliferation of multiple myeloma by targeting PDZ-binding kinase in MAPK pathway},
journal = {Aging},
year = {2024},
doi = {10.18632/aging.205634}
}
EUVIMED